Characteristic | SG (n = 32) | RYGB (n = 32) | P value |
---|---|---|---|
Demographic, mean (SD) | |||
Age (yrs) | 40.4 ± 9.4 | 41.4 ± 9.3 | 0.681 |
Sex, female-no.(%) | 23 (71.9) | 19 (59.4) | 0.292 |
Height (cm) | 166.8 ± 6.8 | 170.3 ± 8.6 | 0.077 |
Weight (kg) | 88.4 ± 6.8 | 94.3 ± 13.3 | 0.055 |
Body mass index (kg/m2) | 31.8 ± 3.0 | 32.3 ± 2.4 | 0.374 |
Waist circumference (cm) | 103.0 ± 7.7 | 104.5 ± 6.8 | 0.404 |
Duration of diabetes (yrs) | 4.0 ± 1.7 | 4.2 ± 1.9 | 0.710 |
Glycemia, mean (SD) | |||
HbA1c (%) | 8.5 ± 1.2 | 8.9 ± 1.3 | 0.321 |
FBG (mmol/L) | 10.2 ± 2.7 | 10.4 ± 2.2 | 0.700 |
C-peptide (ng/ml) | 2.2 ± 0.7 | 2.6 ± 1.0 | 0.062 |
Serum lipids, mean (SD) | |||
Cholesterol (mmol/L) | 5.0 ± 1.1 | 4.6 ± 0.9 | 0.092 |
Triglyceride (mmol/L) | 3.2 ± 1.7 | 3.0 ± 2.0 | 0.545 |
HDL (mmol/L) | 1.1 ± 0.2 | 1.0 ± 0.1 | 0.067 |
LDL (mmol/L) | 3.8 ± 1.1 | 3.9 ± 0.9 | 0.702 |
Medication usage-no.(%) | |||
Oral hypoglycemic | 31 (96.9) | 30 (93.8) | 0.554 |
Insulin usage | 15 (46.9) | 18 (56.2) | 0.453 |
Antihypertension | 10 (31.2) | 12 (37.5) | 0.599 |
Lipid-lowering drug | 21 (65.6) | 18 (56.2) | 0.442 |